Independent Solutions Wealth Management LLC lessened its position in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 83.2% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 787 shares of the semiconductor company's stock after selling 3,888 shares during the period. Independent Solutions Wealth Management LLC's holdings in Synopsys were worth $399,000 at the end of the most recent quarter.
Several other large investors have also recently bought and sold shares of SNPS. Chris Bulman Inc bought a new stake in shares of Synopsys in the second quarter worth $30,000. Pacifica Partners Inc. bought a new stake in shares of Synopsys in the 3rd quarter valued at about $25,000. Tsfg LLC increased its stake in shares of Synopsys by 75.0% in the third quarter. Tsfg LLC now owns 56 shares of the semiconductor company's stock valued at $28,000 after buying an additional 24 shares during the period. Hazlett Burt & Watson Inc. raised its position in shares of Synopsys by 40.0% during the third quarter. Hazlett Burt & Watson Inc. now owns 70 shares of the semiconductor company's stock worth $35,000 after acquiring an additional 20 shares during the last quarter. Finally, Fairscale Capital LLC acquired a new position in shares of Synopsys in the second quarter worth approximately $51,000. 85.47% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
Several research analysts have issued reports on SNPS shares. JPMorgan Chase & Co. raised their price target on shares of Synopsys from $655.00 to $685.00 and gave the stock an "overweight" rating in a report on Thursday, August 22nd. Rosenblatt Securities reissued a "buy" rating and set a $635.00 target price on shares of Synopsys in a research note on Wednesday, December 4th. Loop Capital initiated coverage on shares of Synopsys in a research report on Monday, November 11th. They set a "buy" rating and a $675.00 price target on the stock. Needham & Company LLC reissued a "buy" rating and issued a $640.00 price objective on shares of Synopsys in a research report on Thursday, December 5th. Finally, Mizuho started coverage on Synopsys in a research report on Tuesday, October 22nd. They set an "outperform" rating and a $650.00 target price on the stock. One equities research analyst has rated the stock with a hold rating and ten have given a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $649.00.
Read Our Latest Stock Analysis on Synopsys
Synopsys Trading Down 0.2 %
NASDAQ SNPS traded down $1.08 during mid-day trading on Thursday, hitting $493.35. The company's stock had a trading volume of 1,132,331 shares, compared to its average volume of 1,080,738. The company's 50 day simple moving average is $529.92 and its 200 day simple moving average is $540.69. The firm has a market capitalization of $75.79 billion, a price-to-earnings ratio of 33.98, a PEG ratio of 3.41 and a beta of 1.08. Synopsys, Inc. has a twelve month low of $457.52 and a twelve month high of $629.38.
About Synopsys
(
Free Report)
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Recommended Stories
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.